Benchmark Indices Fall Below Key Levels; Pharma Leads Losses While FMCG and Auto Show Relative Strength as Investors Await Q1 Earnings

Indian equity markets witnessed a sharp correction on Wednesday as a combination of rising crude oil prices, renewed geopolitical tensions in the Middle East, and fresh concerns over the outlook for pharmaceutical exports triggered broad-based selling across sectors. Investors remained cautious ahead of a busy earnings calendar, while uncertainty surrounding global trade policies and interest rate expectations further dampened market sentiment.

The benchmark indices traded under pressure throughout the morning session, with weakness visible across large-cap, mid-cap, and small-cap stocks.

Benchmarks Slip Below Crucial Levels

At around 10:00 AM, the BSE Sensex was trading at 76,883.91, down 586 points (0.76%), while the Nifty 50 slipped 168.25 points (0.70%) to 24,019.45. During intraday trading, the Sensex briefly declined by more than 600 points, reflecting heightened risk aversion among investors.

Market participants attributed the decline to a combination of global and domestic factors, including higher crude oil prices, uncertainty surrounding the US-Iran conflict, and profit booking after the recent rally in Indian equities.

Crude Oil Surge Rekindles Inflation Concerns

One of the biggest factors weighing on investor sentiment was the sharp rise in crude oil prices. Escalating tensions between the United States and Iran have increased concerns over possible disruptions to global oil supplies, pushing international crude prices higher.

India imports more than 80% of its crude oil requirements, making higher oil prices a significant macroeconomic concern. Rising crude prices typically increase inflationary pressures, widen the country's current account deficit, and raise input costs for industries such as aviation, paints, chemicals, logistics, and transportation.

The sustained rise in oil prices could also complicate the Reserve Bank of India's inflation management strategy if energy costs remain elevated over an extended period.

Pharma Stocks Face Fresh Headwinds

The pharmaceutical sector emerged as the biggest loser of the day after fresh policy announcements from the United States raised concerns about the future profitability of Indian generic drug manufacturers.

The Nifty Pharma Index declined more than 1% after the US administration proposed imposing a 100% tariff on imported generic medicines from 2028, with the tariff expected to rise to 200% from 2029.

Although these measures would take effect several years later, investors reacted cautiously because the United States remains the largest export destination for India's pharmaceutical industry. Higher tariffs could potentially reduce price competitiveness and impact long-term earnings visibility for Indian drug makers.

Among the major losers were Cipla, Lupin, Gland Pharma, Piramal Pharma, and several other export-oriented pharmaceutical companies.

Broader Markets Mirror Weakness

The selling pressure was not confined to benchmark stocks.

The Nifty MidCap Index declined around 0.59%, while the Nifty SmallCap Index slipped 0.92%, indicating widespread profit booking across broader market segments.

Market experts noted that investors preferred reducing exposure to high-beta stocks amid increasing global uncertainty and a cautious earnings season.

Sectoral Performance Remains Mixed

Most sectoral indices traded in negative territory during the session.

Major Losers

• Pharma

• Healthcare

• Financial Services

• Banking

• Realty

• IT

Relatively Strong Performers

• FMCG

• Auto

• Consumer Durables

Defensive buying in FMCG stocks helped limit overall market losses, while select automobile stocks found support after encouraging quarterly earnings announcements.

IndiGo, Cipla and Axis Bank Drag Benchmarks

Among the Nifty50 constituents, InterGlobe Aviation (IndiGo), Cipla, and Axis Bank emerged as the biggest drags on the benchmark indices.

Aviation stocks remained under pressure due to rising aviation turbine fuel costs resulting from higher crude oil prices, while banking stocks witnessed profit booking after recent gains.

TVS Motor Surges on Strong Earnings

Despite the weak market, TVS Motor Company bucked the trend by gaining nearly 3% following its robust first-quarter FY27 results.

The company reported healthy revenue growth, improved operating margins, and strong profitability supported by effective cost management and favourable currency movements. Several brokerage firms maintained positive ratings on the stock, citing strong demand across domestic and export markets.

Paras Defence Expands Semiconductor Presence

Shares of Paras Defence and Space Technologies remained in focus after its subsidiary announced plans to establish a greenfield Outsourced Semiconductor Assembly and Test (OSAT) facility in Madhya Pradesh.

The project is expected to strengthen India's semiconductor ecosystem and aligns with the government's efforts to promote domestic electronics manufacturing under the "Make in India" initiative.

Gold Rises as Investors Seek Safety

While equities declined, gold prices moved closer to a two-week high as investors shifted towards safe-haven assets.

Apart from geopolitical concerns, traders are also awaiting next week's US Federal Reserve policy meeting for fresh guidance on future interest rate decisions. Expectations regarding the Fed's monetary policy continue to influence global capital flows and commodity markets.

Primary Market Activity Continues

Despite volatility in secondary markets, investor interest in the primary market remained healthy.

IPOs Open for Subscription

• Cube Highways Trust InvIT

• Shree Balaji Mala IPO

Ongoing Public Issues

• Metalic Technoforge IPO (Second Day)

• Gulf Lloyds IPO (Third Day)

Market participants will closely monitor subscription trends as volatility in the secondary market may influence retail participation.

Q1 Earnings in Focus

Corporate earnings remain the biggest domestic trigger for equity markets this week. Several prominent companies are scheduled to announce their April–June quarter results, including:

• Adani Green Energy

• Adani Power

• Bharat Petroleum Corporation (BPCL)

• Dr. Reddy's Laboratories

• HFCL

• HPCL

• IIFL Finance

• IndusInd Bank

• JSW Energy

• Nestlé India

• Nippon Life India Asset Management

• Oracle Financial Services Software

• SRF

• Tata Communications

• Tanla Platforms

• UCO Bank

• United Spirits

• UTI Asset Management Company

Investors will closely examine management commentary, demand trends, margin performance, and forward guidance to assess the strength of corporate earnings amid an uncertain global environment.

What Investors Should Watch Next

Going forward, market direction is likely to be influenced by several key developments:

• Movement in global crude oil prices amid Middle East tensions.

• Corporate earnings from large-cap companies across banking, IT, FMCG, pharma, and energy sectors.

• Developments regarding US trade and tariff policies affecting Indian exporters.

• Global market trends and institutional investor flows.

• Signals from the upcoming US Federal Reserve policy meeting.

• Foreign Institutional Investor (FII) and Domestic Institutional Investor (DII) activity.